Sudarshan Pharma Industries Limited (BOM:543828)
India flag India · Delayed Price · Currency is INR
31.90
+0.37 (1.17%)
At close: Nov 6, 2026

BOM:543828 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
290.26233.03149.3114.5570.3752.48
Depreciation & Amortization
47.6537.8828.0612.299.078.66
Loss (Gain) From Sale of Assets
-13.57-10.2----
Loss (Gain) From Sale of Investments
-0.24-0.84-1.11---
Provision & Write-off of Bad Debts
40.973.9719.54---
Other Operating Activities
336.35225.9145.7596.1652.6633
Change in Accounts Receivable
-861.08-767.01-376.12-415.71-80.33-130.83
Change in Inventory
-813.81-758.55-547.43-97.98-276.98-229.06
Change in Accounts Payable
366.25972.51316.16-332.55181.38295.33
Change in Other Net Operating Assets
-53.3640.31-57.39720.09-244.11-67.8
Operating Cash Flow
-660.58-22.99-323.2496.86-287.93-38.22
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-489.29-690.97-212.45-37.84-143.27-16.56
Sale of Property, Plant & Equipment
73.511.49----
Cash Acquisitions
-470-20.69-0.64-29.97--
Investment in Securities
-299.65-299.651-15-123.39-
Other Investing Activities
96.57222.855.55-8.0310.141.99
Investing Cash Flow
-1,089-776.97-206.54-90.84-256.52-14.57

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-947.2659.06---
Long-Term Debt Issued
-101.36--78.4912.03
Total Debt Issued
2,0041,049659.06-78.4912.03
Long-Term Debt Repaid
--10.28-8.29-22.97--
Lease Payments
-9.49-10.28-8.16---
Net Debt Issued (Repaid)
1,9271,038650.77-22.9778.4912.03
Issuance of Common Stock
----641.6120.19
Common Dividends Paid
----7.22--
Other Financing Activities
-174.07-246.59-117.31-91.63-60.8210.38
Financing Cash Flow
1,753791.69533.47-121.82659.2842.61

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
-0.2714.10.38---
Net Cash Flow
3.25.844.07-115.8114.83-10.19

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-1,150-713.96-535.6959.02-431.2-54.79
Free Cash Flow Growth
------
Free Cash Flow Margin
-14.74%-10.15%-10.61%1.27%-9.35%-1.53%
Free Cash Flow Per Share
-4.71-2.93-2.210.25-1.79-0.38
Levered Free Cash Flow
-1,919-1,128-603.47-731.33-447.11-89.26
Unlevered Free Cash Flow
-1,734-985.16-515.77-682.14-418.45-72.02
Free Cash Flow After Leases
-1,159-724.24-543.8659.02-431.2-54.79

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
288.71246.59155.5290.2854.0233.79
Cash Income Tax Paid
65.8560.2129.3821.2221.0617.68
Change in Working Capital
-1,362-512.74-664.78-126.15-420.03-132.35